Oncology and Hematology Associates of Southwest Virginia, Inc., dba Blue Ridge Cancer Care — Roanoke, Virginia

Oncology and Hematology Associates of Southwest Virginia, Inc., dba Blue Ridge Cancer Care is a clinical research site located in Roanoke, Virginia, United States 24014.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Oncology and Hematology Associates of Southwest Virginia, Inc., dba Blue Ridge Cancer Care has participated in 1 clinical trials.

Therapeutic areas: Colorectal Cancer.

Sponsors: HiberCell, Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncology and Hematology Associates of Southwest Virginia, Inc., dba Blue Ridge Cancer Care?

Oncology and Hematology Associates of Southwest Virginia, Inc., dba Blue Ridge Cancer Care has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncology and Hematology Associates of Southwest Virginia, Inc., dba Blue Ridge Cancer Care conducted?

Oncology and Hematology Associates of Southwest Virginia, Inc., dba Blue Ridge Cancer Care has 1 clinical trials on record. Their work covers Colorectal Cancer.

Is Oncology and Hematology Associates of Southwest Virginia, Inc., dba Blue Ridge Cancer Care accredited by Crixeo Health?

Oncology and Hematology Associates of Southwest Virginia, Inc., dba Blue Ridge Cancer Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oncology and Hematology Associates of Southwest Virginia, Inc., dba Blue Ridge Cancer Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.